RYTM

Rhythm Pharmaceuticals, Inc.

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$86.29

Market Cap

$5.89B

Beta

2.15

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+45.83%

EPS Growth (YoY)+27.84%

Revenue CAGR 3Y+100.23%

P/E Ratio0.0

PEG Ratio—

FCF Yield-1.98%

Debt / Equity1.77

Interest Coverage-9.3x

No credit card required

Already have an account? Sign in to view the full analysis for RYTM.